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AntitumourThe aim of this study was to investigate the chemical composition and anticancer effect of the leaf essen-
tial oil of Xylopia frutescens in experimental models. The chemical composition of the essential oil was
analysed by GC/FID and GC/MS. In vitro cytotoxic activity of the essential oil was determined on cultured
tumour cells. In vivo antitumour activity was assessed in Sarcoma 180-bearing mice. The major com-
pounds identiﬁed were (E)-caryophyllene (31.48%), bicyclogermacrene (15.13%), germacrene D (9.66%),
d-cadinene (5.44%), viridiﬂorene (5.09%) and a-copaene (4.35%). In vitro study of the essential oil dis-
played cytotoxicity on tumour cell lines and showed IC50 values ranging from 24.6 to 40.0 lg/ml for
the NCI-H358M and PC-3M cell lines, respectively. In the in vivo antitumour study, tumour growth inhi-
bition rates were 31.0–37.5%. In summary, the essential oil was dominated by sesquiterpene constituents
and has some interesting anticancer activity.
 2013 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Xylopia frutescens Aubl. (Annonaceae) is a medicinal plant found
in Central and South America, Africa and Asia (Braga, 1976). In Bra-
zil, it is popularly known as ‘‘embira’’, ‘‘embira-vermelha’’ and ‘‘pau
carne’’, and its seeds are used in folk medicine as a bladder stimu-
lant, to trigger menstruation, and to combat rheumatism, halitosis,
tooth decay and intestinal diseases (Correa, 1984; Takahashi,
Boaventura, Bayma, & Oliveira, 1995). The seeds have an acrid, aro-
matic taste and are used instead of pepper in Guyana. In Panama,
its leaves are used to treat fever (Joly et al., 1987). Studies examin-
ing the biological properties of X. frutescens have demonstrated
antibacterial, antifungal, anti-viral, antiplasmodial and anti-
inﬂammatory activities (Braga, Wagner, Lombardi, & Oliveira,
2000; Fournier et al., 1994; Jenett-Siems, Mockenhaupt, Bienzle,
Gupta, & Eich, 1999; Matsuse, Lim, Hattori, Correa, & Gupta, 1999).
Numerous studies have demonstrated anticancer activity for
the essential oils obtained from medicinal plants (Asekun & Ade-
niyi, 2004; Britto et al., 2012; Quintans et al., 2013; Ribeiro et al.,2012; Sœur et al., 2011). In this work, we evaluated the chemical
composition and in vitro and in vivo anticancer effects of the leaf
essential oil of X. frutescens.
2. Materials and methods
2.1. Cells
The cytotoxicity assay was performed using OVCAR-8 (ovarian
adenocarcinoma), NCI-H358M (bronchoalveolar lung carcinoma)
and PC-3M (metastatic prostate carcinoma) human tumour cell
lines, all obtained from the National Cancer Institute, Bethesda,
MD. Cells were grown in RPMI-1640 medium supplemented with
10% foetal bovine serum, 2 mM glutamine, 100 lg/ml streptomy-
cin and 100 U/ml penicillin. Cells were maintained at 37 C in a
5% CO2 atmosphere.
Sarcoma 180 tumour cells, which had been maintained in the
peritoneal cavity of Swiss mice, were obtained from the Laboratory
of Experimental Oncology at the Federal University of Ceará, Brazil.
2.2. Animals
A total of 40 Swiss mice (males, 25–30 g), obtained from the
central animal house at the Federal University of Sergipe, Brazil,
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and water. All animals were kept under a 12:12 h light–dark cycle
(lights on at 6:00 a.m.). Animals were treated according to the eth-
ical principles for animal experimentation of SBCAL (Brazilian
Association of Laboratory Animal Science), Brazil. The Animal Stud-
ies Committee at the Federal University of Sergipe approved the
experimental protocol (number 08/2012).
2.3. Plant material
X. frutescens leaves were collected in July 2011 at ‘‘Mata do Jun-
co’’ in the Municipality of Capela, Sergipe State, Brazil, coordinates:
S 10 570 5200 W 37 040 6500. The species was identiﬁed by Dr. Ana
Paula do Nascimento Prata. Voucher specimen number 22178 was
deposited at the Herbarium of the Federal University of Sergipe,
Brazil. The leaves were obtained from plants that were ﬂowering
and in fructiﬁcation.
2.4. Hydrodistillation of the volatile constituents
X. frutescens leaves (200 g) were dried in an oven with circulat-
ing air at 40 C for 24 h and submitted to hydrodistillation for 4 h
using a Clevenger-type apparatus (Amitel, São Paulo, Brazil). The
essential oil was dried over anhydrous sodium sulfate and the per-
centage content (v/w) was calculated on the basis of the dry weight
of plant material. The essential oils were stored in a freezer until
analysis. Hydrodistillation was performed in triplicate.
2.5. GC analysis
GC analyses were carried out using a Shimadzu GC-17A ﬁtted
with a ﬂame ionisation detector (FID) and an electronic integrator
(Shimadzu, Kyoto, Japan). Separation of the compounds was
achieved using a ZB-5MS fused capillary column
(30 m  0.25 mm  0.25 lm ﬁlm thickness; Phenomenex, Tor-
rance, CA). Helium was the carrier gas at 1.0 ml/min ﬂow rate.
The column temperature program was: 40 C for 4 min, a rate of
4 C/min to 240 C, then a rate of 10 C/min to 280 C, and then
280 C for 2 min. The injector and detector temperatures were
250 C and 280 C, respectively. Samples (10 mg/ml in CH2Cl2)
were injected with a 1:50 split ratio. The injection volume was
0.5 ll. Retention indices were generated with a standard solution
of n-alkanes (C8–C20). Peak areas and retention times were mea-
sured by an electronic integrator. The relative amounts of individ-
ual compounds were computed from GC peak areas without FID
response factor correction.
2.6. GC/MS analysis
GC/MS analyses were performed on a Shimadzu QP5050A GC/
MS system equipped with an AOC-20i auto-injector. A J&W Scien-
tiﬁc DB-5MS fused capillary column (30 m  0.25 mm  0.25 lm
ﬁlm thickness; Agilent, Santa Clara, CA) was used as the stationary
phase. MS data were taken at 70 eV with a scan interval of 0.5 s
from m/z 40 to 500. All other conditions were similar to the GC
analysis.
2.7. Identiﬁcation of constituents
Essential oil components were identiﬁed by comparing the
retention times of the GC peaks with standard compounds run un-
der identical conditions and by comparison of retention indices
(Van Den Dool & Kratz, 1963) andmass spectra (Adams, 2007) with
those found in the literature, and by comparison of mass spectra
with those stored in the NIST 107 and NIST 21, and Wiley 229
libraries.2.8. In vitro cytotoxic activity assay
Tumour cell growth was determined by the ability of living cells
to reduce the yellow dye 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphe-
nyl-2H-tetrazolium bromide (MTT) to a purple formazan product,
as described by Mossman (1983). For all experiments, cells were
seeded in 96-well plates (0.7  105 cells/ml for adherent cells or
0.3  106 cells/ml for suspended cells in 100 ll of medium). After
24 h, the drugs (0.78–50 lg/ml) were dissolved in pure DMSO
and added to each well using HTS – High-Throughput Screening
(Biomek 3000, Beckman Coulter Inc., Fullerton, CA). Then, the cells
were incubated for 72 h. Doxorubicin (purity > 98%; Sigma Chemi-
cal Co., St. Louis, MO) was used as positive control. At the end of
incubation, the plates were centrifuged, and the medium was re-
placed by fresh medium (150 ll) containing 0.5 mg/ml MTT. Three
hours later, the formazan product was dissolved in 150 ll DMSO,
and absorbance was measured using a multiplate reader (DTX
880 Multimode Detector, Beckman Coulter Inc.). The drug effects
were expressed as the percentage of control absorbance of reduced
dye at 595 nm.
2.9. In vivo antitumour activity assay
The in vivo antitumour effect was evaluated using Sarcoma 180
ascites tumour cells, following protocols previously described
(Bezerra et al., 2006, 2008; Britto et al., 2012). Ten-day-old Sar-
coma 180 ascites tumour cells (2  106 cells per 500 ll) were im-
planted subcutaneously into the left hind groin of mice. The
essential oil was dissolved in 5% DMSO and given to mice intraper-
itoneally once a day for 7 consecutive days. At the beginning of the
experiment, the mice were divided into four groups of 8–15 ani-
mals as follows: Group 1: animals treated by injection of vehicle
5% DMSO (n = 15); Group 2: animals treated by injection of 5-ﬂuo-
rouracil (5-FU, purity > 99%; Sigma Chemical Co.) (25 mg/kg/day)
(n = 9); Group 3: animals treated by injection of the essential oil
(50 mg/kg/day) (n = 8); Group 4: animals treated by injection of
the essential oil (100 mg/kg/day) (n = 8). The treatments were
started one day after tumour injection. The dosages were deter-
mined based on previous articles. On Day 8, the animals were sac-
riﬁced by cervical dislocation, and the tumours were excised and
weighed. The drug effects were expressed as the percent inhibition
of control.
Body mass loss, organ weight alterations and haematological
analysis were determined at the end of the above experiment, as
described by Britto et al. (2012). Peripheral blood samples of the
mice were collected from the retro-orbital plexus under light ether
anaesthesia, and the animals were sacriﬁced by cervical disloca-
tion. After sacriﬁce, the livers, kidneys and spleens were removed
and weighed. In haematological analysis, total leukocyte counts
were determined by standard manual procedures using light
microscopy.
2.10. Statistical analysis
Data are presented as mean ± SEM/SD or half maximal inhibi-
tory concentration (IC50) values and their 95% conﬁdence intervals
(CI 95%) obtained by nonlinear regression. The differences between
experimental groups were compared by ANOVA (analysis of vari-
ance) followed by the Student–Newman–Keuls test (p < 0.05). All
statistical analyses were performed using the GraphPad program
(Intuitive Software for Science, San Diego, CA).
3. Results and discussion
Hydrodistillation of X. frutescens leaves gave a colourless crude
essential oil with a yield of 1.00 ± 0.09%, in relation to the dry
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identify 34 compounds according to GC/MS and GC/FID analysis.
The major compounds identiﬁed were (E)-caryophyllene
(31.48%), bicyclogermacrene (15.13%), germacrene D (9.66%),
d-cadinene (5.44%), viridiﬂorene (5.09%) and a-copaene (4.35%).
Some phytochemical studies on the stem bark and fruit from X.
frutescens have been previously reported (Fournier et al., 1994;
Leboeuf, Cave, Provost, Forgacs, & Janquemin, 1982; Melo, Cota,
Oliveira, & Braga, 2001; Rocha, Silva, & Panizza, 1980; Sena-Filho,
Duringer, Craig, & Schuler, 2008; Takahashi et al., 1995). Particu-
larly, germacrene D (24.2%), linalool (12.1%), b-pinene (8.0%),
cis-sabinene hydrate (7.9%), trans-pinocarveol (7.8%), a-copaene
(7.0%) and limonene (5.6%) were the major compounds identiﬁed
in X. frutescens fruits (Sena-Filho et al., 2008). a-Cubebene
(25.2%) and d-cadinol (27.4%) were the compounds identiﬁed in
its stem bark (Fournier et al., 1994).
In genus Xylopia, bicyclogermacrene (36.5%), spathulenol
(20.5%) and limonene (4.6%) were found in leaf essential oil of
Xylopia aromatica. Xylopia cayennensis was composed of a-pinene
(29.2%), b-pinene (16.5%), caryophyllene oxide (14.5%), bicycloger-
macrene (14.5%), germacrene D (4.7%) and 1,8-cineole (4.5%). Xyl-
opia emarginata was dominated by spathulenol (73.0%). For
Xylopia nitida, c-terpinene (44.1%), p-cymene (13.7%), a-terpinene
(12.6%) and limonene (11.3%) were identiﬁed (Maia et al., 2005). In
another study with leaf essential oil of X. aromatica the major com-
pounds were a-pinene (26.1%), limonene (22.3%), bicyclogermac-
rene (20.4%) and b-pinene (19.0%) (Lago et al., 2003). TheTable 1
Chemical composition of the leaf essential oil of Xylopia frutescens.
Compound RIa RIb Leaf oil%
1 (E)-b-Ocimene 1047 1044 0.41 ± 0.70
2 a-Cubebene 1348 1345 0.92 ± 0.03
3 a-Ylangene 1370 1373 0.64 ± 0.03
4 a-Copaene 1377 1374 4.35 ± 0.27
5 b-Elemene 1390 1389 0.93 ± 0.20
6 a-Gurjunene 1408 1409 0.47 ± 0.04
7 (E)-Caryophyllene 1422 1417 31.48 ± 1.47
8 b-Copaene 1431 1430 0.53 ± 0.05
9 Aromadendrene 1440 1439 3.21 ± 0.28
10 trans-Muurola-3,5-diene 1450 1451 0.40 ± 0.03
11 a-Humulene 1457 1452 2.60 ± 0.21
12 allo-Aromadendrene 1461 1458 0.74 ± 0.03
13 cis-Cadina-1(6),4-diene 1464 1461 0.15 ± 0.03
14 c-Muurolene 1476 1478 3.26 ± 0.25
15 Germacrene D 1483 1484 9.66 ± 2.18
16 Viridiﬂorene 1492 1496 5.09 ± 0.46
17 Bicyclogermacrene 1497 1500 15.13 ± 2.44
18 d-Amorphene 1504 1511 0.19 ± 0.17
19 c-Cadinene 1514 1513 1.69 ± 0.25
20 d-Cadinene 1519 1522 5.44 ± 0.91
21 cis-Calamenene 1523 1528 0.79 ± 0.06
22 trans-Cadina-1,4-diene 1534 1533 0.53 ± 0.10
23 a-Cadinene 1538 1537 0.32 ± 0.08
24 Germacrene B 1561 1559 0.40 ± 0.12
25 (Z)-Dihydro-apofarnesal 1573 1571 0.45 ± 0.07
26 Spathulenol 1579 1577 1.35 ± 0.27
27 Caryophyllene oxide 1585 1582 0.61 ± 0.02
28 Globulol 1588 1590 1.36 ± 0.50
29 Viridiﬂorol 1597 1592 0.19 ± 0.33
30 Rosifoliol 1609 1600 0.54 ± 0.15
31 1-epi-Cubebol 1630 1627 0.45 ± 0.10
32 epi-a-Cadinol 1644 1638 0.97 ± 0.50
33 a-Muurolol 1648 1644 0.24 ± 0.25
34 a-Cadinol 1658 1652 1.00 ± 0.68
Monoterpene identiﬁed 0.41
Sesquiterpene identiﬁed 96.10
Total identiﬁed 96.51
Data are expressed as mean ± SD of three analyses. RI (retention indices).
a Calculated on DB-5MS column according to Van Den Dool and Kratz (1963),
based on a homologous series of normal alkanes.
b According to Adams (2007).essential oil of Xylopia sericea contained cubenol (57.4%) and
a-epi-muurolol (26.1%) as the main compounds found in the
leaves, while b-pinene (45.6%) and a-pinene (17.2%) were the main
compounds found in the fruits (Pontes et al. (2007). Tavares et al.
(2007) investigated the chemical constituents from leaves of Xyl-
opia langsdorfﬁana and observed that the major compounds were
germacrene D (22.9%), trans-b-guaiene (22.6%), (E)-caryophyllene
(15.7%) and a-pinene (7.3%).
Quintans et al. (2013) analysed the chemical composition of
three specimens of X. laevigata and observed that c-muurolene
(0.60–7.99%), d-cadinene (1.15–13.45%), germacrene B (3.22–
7.31%), a-copaene (3.33–5.98%), germacrene D (9.09–60.44%),
bicyclogermacrene (7.00–14.63%) and (E)-caryophyllene (5.43–
7.98%) were the major constituents in all samples of the essential
oils. Although some chemical constituents present in the leaf oil
of X. frutescens have been found in the essential oils from other
Brazilian Xylopia species, recent studies as described above have
demonstrated signiﬁcant variations in the essential oils from the
various species belonging to this genus. However, (E)-caryophyl-
lene, bicyclogermacrene, germacrene D and a- and b-pinene, pres-
ent in high concentration in most of the species investigated,
appear to be the main compounds in the essential oil from the Bra-
zilian Xylopia species.
Cytotoxicity was assessed against OVCAR-8 (ovarian adenocar-
cinoma), NCI-H358M (bronchoalveolar lung carcinoma) and PC-
3M (metastatic prostate carcinoma) human tumour cell lines using
the thiazolyl blue test (MTT) assay. Table 2 shows the obtained IC50
values. The essential oil showed IC50 values ranging from 24.6 to
40.0 lg/ml for the NCI-H358M and PC-3M cell lines, respectively.
Doxorubicin, used as positive control, showed IC50 values from
0.9 to 1.6 lg/ml for the NCI-H358M and PC-3M cell lines, respec-
tively. According to Suffness and Pezzuto (1990), those extracts
presenting IC50 values below 30 lg/ml in tumour cell line assays
are considered promising for anticancer drug development. Thus,
the essential oil obtained from X. frutescens presented promising
results. Interestingly, cytotoxic activities have also been reported
for the essential oils from some plants belonging to the Xylopia
species, such as X. aethiopica (Asekun & Adeniyi, 2004). These ef-
fects have been associated with a mixture of the major and minor
constituents of these essential oils.
The leaf essential oil of X. frutescens was also able to inhibit tu-
mour growth in mice in a dose-dependent manner. In the in vivo
antitumour study, mice were subcutaneously transplanted with
Sarcoma 180 cells and treated by the intraperitoneal route once a
day for 7 consecutive days with the essential oil. The effects of
the essential oil on mice implanted with Sarcoma 180 tumour cells
are presented in Fig. 1. On Day 8, the average tumour weight of the
control mice was 1.93 ± 0.13 g. In the presence of the essential oil
(50 and 100 mg/kg/day), the average tumour weights were
1.33 ± 0.19 and 1.20 ± 0.10 g, respectively. Tumour growth inhibi-
tion rates were 31.0–37.5%. 5-FU (25 mg/kg/day), used as positive
control, reduced tumour weight by 63.2%.Table 2
In vitro cytotoxic activity of the leaf essential oil of Xylopia frutescens.
Cell lines Histotype Doxorubicin Essential oil
OVCAR-8 Ovarian adenocarcinoma 1.2 33.9
0.9–1.6 24.9–46.3
NCI-H358M Bronchoalveolar lung carcinoma 0.9 24.6
0.6–1.3 14.9–40.7
PC-3M Metastatic prostate carcinoma 1.6 40.0
1.1–2.4 31.3–51.2
Data are presented as IC50 values in lg/ml and their 95% conﬁdence interval
obtained by nonlinear regression from two independent experiments performed in
duplicate, measured by MTT assay after 72 h of incubation. Doxorubicin was used as
positive control.
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Fig. 1. In vivo antitumour effect of the leaf essential oil of Xylopia frutescens. Mice
were injected with Sarcoma 180 tumour cells (2.0  106 cells/animal, s.c.). The
animals were treated by intraperitoneal administration for seven consecutive days,
starting one day after tumour implantation. 5-Fluorouracil (5-FU, 25 mg/kg/day)
was used as positive control. Negative control was treated with the vehicle used for
diluting the tested substance (5% DMSO). Data are presented as mean ± SEM of 8–15
animals. ⁄p < 0.05 compared with the 5% DMSO group.
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essential oil-treated mice using the experimental protocol de-
scribed above. Table 3 shows the obtained data. No signiﬁcant
changes in the weight of livers, kidneys or spleens were seen in
the essential oil-treated groups (p > 0.05). No signiﬁcant changes
in body weight gain were observed either (p > 0.05). In addition,
essential oil-treated animals showed a signiﬁcant increase in total
numbers of circulating peripheral leukocytes, compared to the con-
trol group (p < 0.05). These results indicate that the essential oil in-
creased the cell types involved in the primary defence mechanism.
In contrast, 5-FU, used as positive control, reduced the body
weights and spleen organ weights and induced a decrease in total
leukocytes (p < 0.05).
In conclusion, the leaf essential oil of X. frutescens is character-
ised by the presence of (E)-caryophyllene, bicyclogermacrene,
germacrene D, d-cadinene, viridiﬂorene and a-copaene. In addi-
tion, it exhibited in vitro and in vivo anticancer effects without an
expressive toxicity. Further studies must be carried out to better
understand the underlying mechanism involved in the anticancer
activity of this essential oil.Conﬂict of interest
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